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Abstract
The endoscopic management of large colonic polyps is a rapidly changing
field. Rapid evolution in endoscopic techniques and skills has resulted in
diminishing the role of surgery in the management of larger and complex
polyps. This is resulting in organ preservation for many who otherwise would
have undergone surgery. However, it also poses new challenges. This article
reviews these new advances and the developments which are overcoming
these difficulties.
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Introduction
Colorectal cancer is the fourth leading cause of cancer death 
in the UK, responsible for 15,903 deaths in 2014. Despite this, 
54% of cases are preventable1. This is because cancers develop 
predominately through the adenoma carcinoma sequence and 
for a long time are benign adenomatous polyps2. Some cancers 
in the right colon develop along different pathways, but again 
these exist for a long time as benign serrated polyps (sessile 
serrated polyps) before undergoing malignant transformation. 
Removal of these reduces cancer risk, and data from bowel can-
cer screening programmes have shown that the risk of cancer 
death can be reduced through screening and adequate resection of 
polyps3,4. Whilst over 90% of all polyps are small (less than 
10 mm in size), it is not uncommon to find large benign or early 
neoplastic lesions. These can be 40 mm or more in size. The 
morphology of these lesions can be accurately described by 
using the Paris classification system, which classifies lesions as 
pedunculated (1p), sessile (1s), or flat (iia, iib, iic) or, for larger 
lesions, as laterally spreading tumours granular (LST-G) or 
non-granular (LST-NG). This can give some prediction of the 
risk of invasive disease, and non-granular or flat depressed (iic) 
lesions carry a high risk of invasive cancer5. Likewise, assess-
ments of surface and vascular patterns can be used to predict lesion 
histology and, in particular, assess for areas of early invasion6. 
Furthermore, difficult access, the presence of scarring, and loca-
tion close to the dentate line, appendical orifice, ileo-caecal valve, 
or diverticula can make resection very challenging, and resec-
tion of these difficult polyps requires techniques beyond simple 
polypectomy and also poses new risks of complications. These 
risks can be predicted by using classification systems such as 
the size/morphology/site/access (SMSA) scoring system7. In 
this review, we will discuss techniques for the resection of these 
complex polyps and measures that can be taken to minimise 
risks.
Endoscopic mucosal resection
Endoscopic mucosal resection (EMR) involves the injection of 
fluid into the submucosal space to lift the lesion away from the 
muscle and resection in single or multiple (>2 cm in size) pieces 
by using an electrocautery snare. This technique revolution-
ised the management of large and flat polyps. Endoscopists have 
started removing larger and larger lesions with this technique. 
Studies have demonstrated that this technique is more cost 
effective than surgery, and a large Australian study suggested that 
a mean cost saving of $7,602 USD per patient could be achieved8.
Large trials have shown the clinical benefits of this, and the 
Australian Colonic EMR (ACE) study of 1,134 patients from 
Australia9 and a study of 220 patients from the UK7 both dem-
onstrated that excellent results can be achieved. A recent meta- 
analysis reviewed all of the literature on polyps measuring more 
than 2 cm in size and resected by an endoscopic approach. 
This large analysis of EMR examined 50 studies, including 
6,442 patients and 6,779 large polyps (over 20 mm in size)10, and 
demonstrated an initial success rate of 92%, and 503 patients 
underwent surgery for a non-curative endoscopic resection. Per-
foration and bleeding rates of 1.5% and 6.5%, respectively, were 
observed. Recurrence at follow-up was detected in 13.8% of 
patients. Overall, endoscopic treatment was successful in 90.3% 
of cases. Polyp cancer was found in 8% of cases. Recently, the 
European Society of Gastrointestinal Endoscopy (ESGE) rec-
ommended that the majority of colonic and rectal lesions can be 
effectively removed in a curative way by EMR11.
These data illustrate the strength of EMR, which prevented 
surgery in 90% of patients but does have limitations in terms of 
recurrence and management of superficial polyp cancers. The keys 
to success are lesion recognition skills, training, and experience. 
The ESGE recommends that lesions of more than 20 mm in size 
which are sessile, laterally spreading, or complex are removed by 
an appropriately trained, experienced endoscopist in a specialist 
centre.
Endoscopic submucosal dissection
When the polyps are larger than 20 mm in size and especially 
flat, the risk of cancer in these polyps increases and resection 
by EMR technique results in multi-piece resection, which is 
considered to be associated with a high risk of recurrence12. 
Endoscopic submucosal dissection (ESD) is an oncologically 
superior technique designed to resect lesions in an en-bloc 
fashion. It involves submucosal injection followed by the use of 
an ESD knife to perform mucosal incision, followed by trimming 
of the submucosal edges to allow access to the submucosal plane. 
This is followed by full submucosal dissection resulting in 
an en-bloc resection (Figure 1). This technique is well estab-
lished in Japan, where it was initially developed for the resection 
of early gastric cancers. The advantages of ESD are related to 
en-bloc resection; this allows histological confirmation of 
complete resection (R0), low recurrence, and a complete cure 
for low-risk superficial neoplasia. Studies have demonstrated 
that colorectal ESD has very low recurrence rates (under 2%)13. 
However, complications, particularly perforations, which occur 
in around 5% of cases, are more frequent. The learning curve for 
ESD is long and steep outside Japan because of a lack of 
trainers and training facilities.
ESGE guidelines recommend that in cases where there is a 
high suspicion of submucosal invasion and an en-bloc resec-
tion cannot be achieved with an EMR technique, ESD is 
considered11. This is particularly important if there is a suspi-
cion of a iic depressed area or type V surface pit patterns. Recent 
systematic review and meta-analysis reviewed 97 studies with 
18,764 colorectal lesions resected by standard ESD technique 
and reported a pooled R0 resection rate of 82.9% (95% confi-
dence interval [CI] 80.4–85.1%) and an en-bloc resection rate 
of 91% (95% CI 89.2–92.5%)14. They reported a very low com-
plication rate with delayed bleeding rate at 2.7% (CI 2.2–3.2%), 
perforation at 5.2% (CI 4.4–6.1%), and recurrence at 12 months of 
2% (CI 1.3–3.0%). This study further analysed the results on the 
basis of Asian and non-Asian (Western) studies and found some 
interesting differences. Of note, there was a significantly poor 
outcome and higher complication rates in Western settings. We 
believe that this is due to poor training and lack of a formal 
accreditation process in ESD competence. Until we develop a 
good training structure or make the technique safer, ESD in the 
West should be restricted to experts at high-volume centres.
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Hybrid endoscopic submucosal dissection or knife-
assisted snare resection
Classic ESD in the West is difficult to learn, takes a long time to 
perform, and has higher complication rates. A potential com-
promise solution is a hybrid technique involving components 
of EMR that are well established in the West and ESD. It is also 
called knife-assisted snare resection (KAR), in which an ESD knife 
is used to make a circumferential mucosal incision around the 
lesion followed by snare resection, in either a single piece (small 
lesions or after a significant amount of submucosal dissection) or 
multiple pieces (large lesions or little or no submucosal dissec-
tion). This technique has many advantages. As the initial mucosal 
incision is in the normal mucosa around the lesion, it clearly 
demarks the resection zone. This reduces the risk of recur-
rence. KAR involves much less resection as compared with 
traditional ESD, so this makes it quicker and technically easy for 
Western endoscopists. KAR has also been used in the resec-
tion of very challenging scarred polyps (recurrence following 
previous EMR). A recent series of 42 patients reported the use 
of KAR for the resection of very complex scarred lesions with a 
mean size of 40 mm. The investigators reported that more than 
one attempt was required for complete clearance of lesions in 
35% of patients but that ultimately surgery was avoided in 90% of 
patients15.
This looks very promising, but a recent meta-analysis reported 
that R0 and en-bloc resection rates with the hybrid technique 
were significantly lower than those achieved with the standard 
technique (60.6% and 68.4%, respectively) and had similar 
adverse event rates14. This questions the role of this hybrid 
technique. We feel that it is unfair to compare the outcome of 
this technique with the outcome of ESD and that it would be 
better to compare this technique with EMR.
Making resection safer: management of complications 
of endoscopic resection
Complications represent a barrier to the endoscopic resec-
tion of large benign polyps. These can be broadly divided into 
immediate events, which occur during the procedure, and 
delayed events, which can occur up to 4 weeks after the patient 
has gone home. This includes delayed perforation and delayed 
bleeding.
Intra-procedural bleeding is typically controlled with thermal 
energy from the diathermy unit. There are numerous techniques 
for achieving this, including the tip of the snare or dedicated 
coagulation forceps. The optimum settings for the delivery of 
electrical energy have been the subject of research. It is clear 
that for resection a blended cutting current should be used and 
that pure coagulation should be avoided, as it causes a deep 
thermal injury and increases the risk of perforation14. Likewise, 
a pure cutting current, whilst carrying a low risk of perforation, 
carries a high risk of immediate bleeding15. Once a vessel has 
started bleeding, it is necessary to employ a technique to 
achieve haemostasis. A study of 196 patients suggested that soft 
coagulation using the snare tip could achieve haemostasis in 
91% of cases and that coagulating forceps or clips are required in 
the remaining cases16.
It has been questioned whether prophylactic clip closure of the 
EMR/ESD deficit could reduce the risk of delayed complica-
tions. A study of 524 polyps 2 cm or larger from the United States 
suggested that the risk of delayed post-polypectomy bleeding 
could be reduced from 9.7% to 1.8% through full clipping of 
the deficit17. It should be noted that this was an uncontrolled 
retrospective study; as a result, the ESGE does not currently 
recommend routine endoscopic clip closure to prevent delayed 
bleeding11. However, the same group recently reported a ran-
domised controlled trial (n = 354) and compared post-EMR clip 
closure with no closure after the resection of medium-sized 
lesions (1–4 cm). They reported a significant difference in 
delayed bleeding rates of 6.9% without clip closure as com-
pared with 1.1% after clip closure. This is a compelling piece of 
evidence, but there has been no cost-benefit analysis16,18. Given 
the relatively high cost of clips and the large number required to 
completely close a broad EMR base, an economic modelling 
study from Australia has suggested that the expected cost of 
prophylactic clipping would be €1,106 per lesion compared with 
a cost of €157 per lesion without clipping and that the funds 
needed in order to prevent one case of clinically significant 
bleeding would be €14,826, which the authors concluded was 
not cost effective19. Furthermore, whilst clipping is safe in expe-
rienced hands, there is risk when applying to a mucosal deficit of 
causing a perforation. The technique required is quite different 
to their use in obtaining haemostatic control and it is therefore 
Figure 1. Endoscopic submucosal dissection. The lesion is initially assessed and submucosal lifting performed (A) before a complete 
resection is performed (B). The lesion is resected en-bloc before being pinned out and sent for histopathological examination (C).
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important that, if this approach is to be considered, supervised 
training in the technique must be obtained. We feel that this will 
be a highly desirable approach in high-risk patients who have 
multiple co-morbidities and who are likely to require anti-platelet 
or anti-coagulant drugs immediately after the procedure.
Making resection more effective: reducing recurrence 
risk after endoscopic mucosal resection
There have been a number of proposed methods for reduc-
ing recurrence after EMR. It has been questioned whether soft 
tip coagulation of the edges of the resection margin is of value. 
This is being investigated in the SCAR (Soft Coagulation for the 
Prevention of Adenoma Recurrence) study (ClinicalTrials.gov 
identifier NCT01789749) in Australia20. The preliminary results 
from this randomised controlled trial, published in abstract form 
only, have suggested that recurrence rates fall from 20.6% to 
5.8%. These results should be interpreted with caution, as they 
have yet to be published, and the recurrence rates in the control 
limb were much higher than results previously published by the 
same group where a recurrence rate of 16% was observed9. This 
could suggest issues with training of the multiple endoscopists in 
this larger study or lesion selection.
It has been questioned whether performing an extended EMR 
(X-EMR) could reduce recurrence rates. A study of 471 lesions 
resected by standard EMR and 448 lesions resected by X-EMR 
did not show any reduction in residual or recurrent adenoma at 
follow-up (11.7% versus 10.1%, hazard ratio 0.8, CI 0.5–1.3, 
p = 0.499). However, complications were increased, and there 
was increased intra-procedural bleeding (odds ratio 3.1, 
CI 2.0–5.0, p <0.001)21. Therefore, it is possible that recurrence 
in EMR is not coming from the lesion margin but instead from 
microscopic residual adenoma in endoscopically imperceptible 
tissue bridges between piecemeal resections within the ulcer 
base, where the resections overlap, which cannot be identified by 
visual inspection of the final lesion base. What has become clear, 
however, is that incomplete resection is associated with an 
increased risk of lesion recurrence and that this is less likely to 
occur if the resection is performed by a specialist endoscopist. A 
retrospective study of 257 patients with 269 polyps demonstrated 
the protective effect of a specialist endoscopist, and the odds 
ratio for incomplete resection was 0.13 (CI 0.04–0.41)22. Whilst 
there will be continuing debate as to what defines an ‘expert’, 
this is not an unexpected finding, and it is clear that whilst EMR 
is not as technically demanding as ESD, it should be performed 
by endoscopists who have been trained in the technique and who 
perform such resections on a regular basis with audited outcome 
data.
It is possible to predict the risk of lesion recurrence, and larger 
polyps carry an increased risk of incomplete resection or lesion 
recurrence7,22. Likewise, flat laterally spreading lesions or a poor 
lift also increases the complexity of resection and increases 
risk7,22. The Sydney EMR recurrence tool (SERT) can be used 
to predict the risk of adenoma recurrence. This identified lesion 
size, intra-procedural bleeding, and high-grade dysplasia as inde-
pendent risk factors23. Owing to its nature, it can be applied only 
post-resection but could be of value in stratifying the most 
appropriate first surveillance interval. A classification system 
based on SMSA can be used to risk-stratify lesions (by the 
degree of complexity) prior to endoscopy and could be of benefit 
in the assignment of lesions to the most appropriate endoscopist7.
Lesion assessment prior to resection is critical for reducing not 
only the risk of complications or residual adenoma but also the 
risk of finding covert cancer within the resection specimen. It is 
established that in lesions over 2 cm in size this risk increases. 
This is greatest for non-granular lesions (LST-NG) and those 
with a depressed component, a combined Paris classification of 
flat IIa morphology with a bulky Is component, or a high-risk 
surface pattern. It has also been suggested that a rectosig-
moid location carries greater risk24. In lesions at higher risk of 
covert malignancy, an ESD en-bloc resection is preferable to 
enable accurate pathological staging and determine whether a 
cure has been achieved through the endoscopic resection or 
whether further surgery is needed.
Futuristic look
One of the difficulties of ESD has been in achieving traction 
on the lesion. The most commonly taken approach is a transpar-
ent hood, or cap, on the end of the endoscope, which enables 
the lesion to be physically pushed out of the field of dissection. 
However, research has been conducted in approaches to allow 
access of tissue retractors to facilitate faster and safer submu-
cosal dissection. A novel system of an expandable working cham-
ber with two independent instrument guides has been used in an 
in vivo model to achieve successful ESD with a faster 
procedure time and more effective dynamic tissue retraction 
and instrument triangulation25. It has been suggested that this 
approach may reduce the learning curve for ESD. In a similar 
manner, a three-dimensional printed overtube system with two 
manipulator arms at the tip has been used in an animal study 
with similar results26. A modification of the transanal minimally 
invasive surgery (TAMIS) system has been developed for use in 
ESD27; the modification provides three channels and a sealed 
system, allowing triangulation, retraction, and control of infla-
tion. A more sophisticated development is the master and slave 
transluminal endoscopic robot (MASTER) system, which 
provides a pair of robotic ‘arms’ at the end of the endoscope with 
an L-shaped hook and grasper28. It should be noted that all of 
these technologies are in the development phase and are not 
yet ready for mainstream use but do provide insight into how 
things may move in the future. A simpler approach to achieving 
traction is to attach a clip and string to a lesion and apply 
gentle reaction to open up the submucosal space29. Though crude 
compared with the previous techniques described, this is being 
used in current ESD practice in some centres and does not require 
a significant investment in novel equipment.
Moving beyond mucosal resection
Traditionally, the whole aim in endoscopic resection has been 
to avoid a perforation. However, this view is now being chal-
lenged with the development of full-thickness resection devices. 
A specialised device consisting of a transparent cap with a 
preloaded snare and modified over the scope clip is fitted to a 
standard colonoscope. Grasping forceps are used to pull the 
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lesion into the cap, after which the clip is deployed. The snare is 
then closed and electrocautery applied to make a full-thickness 
resection above the clip (Figure 2). Early studies have shown 
success in lesions up to 20 mm in size30–32. Recently, an endo-
scopic suturing system (Apollo OverStitch) has become available, 
which enables full-thickness sutures to be applied. This has been 
used for the closure of anastomotic dehiscence after colorectal 
cancer resections33 and, in a case series of 12 patients, was shown 
to be successful for the closure of conventional ESD defects34. 
To date, there have been no studies examining its use for full- 
thickness ESD, but there is no conceptual reason why it should 
not be effective for such resections, and the possibilities this could 
open up are intriguing. For scarred lesions where a tissue plane 
cannot be identified, this may be an attractive option. Likewise, 
for early cancers, this could provide an alternative to transanal 
endoscopic microsurgery.
Whilst we have discussed the possibilities of ESD, KAR, and 
full-thickness resection, all of these techniques are challeng-
ing to learn. A device has been developed for shaving such 
lesions off in multiple pieces; known as EndoRotor, this catheter-
based device, passed through the biopsy channel of a standard 
colonoscope, uses suction to pull in mucosa and a rotating 
cold blade to cut the tissue before sucking it in and transporting 
samples to a collection trap. Animal studies have suggested that 
rapid resection of flat or slightly elevated mucosa is possible35. 
It is anticipated that the learning curve for achieving confidence 
will be shorter than that for ESD or KAR, although how it 
compares with EMR is less certain. Whether it could be used for 
scarred lesions is unclear and further studies are needed. Because 
it does not achieve an en-bloc resection, its efficacy, safety, and 
learning curve should be compared with EMR rather than ESD 
or full-thickness resection. It is our contention that its future is 
likely to be dependent on whether it can manage scarred lesions 
unsuitable for conventional EMR, as the latter is already well 
established for the resection of unscarred benign pathology in 
multiple pieces and it is difficult to see how this device could be 
more effective for such lesions.
Conclusions
The last decade has seen a revolution in the management of 
colonic neoplasia, and there has been a paradigm shift from 
surgery towards endoscopic resection; the multitude of options are 
shown in Figure 3. It is our contention that there will be additional 
significant changes in the way we manage these lesions. There 
will be a progressive shift away from EMR towards ESD, and 
hybrid techniques will form a bridge as endoscopists make the 
shift towards adopting this approach, which carries the advan-
tages of lower recurrence rates and en-bloc resection. EMR 
will not in any way disappear (as it is a rapid and safe technique) 
but will be used more for uncomplicated, smaller lesions (under 
40 mm in size) where outcomes are excellent. Therefore, case 
selection will be critical and endoscopists will need to become 
confident in deciding the best approach for a given lesion. The 
boundaries of what is considered endoscopically resectable 
will expand, and there will be a growth in the resection of 
scarred lesions currently being sent for surgery. Furthermore, it 
is probable that some early cancers will be resected endoscopi-
cally. Many of the problems currently faced by the endoscopist 
will improve, including haemostasis control, tissue retraction, and 
tools for managing complications such as perforation. Robotic 
ESD is some way off but should not be dismissed as fantasy and 
indeed may be the shape of the future, and organ preservation is 
more realistic than ever before.
Figure 2. Full-thickness resection. The lesion (A) is pulled into the device (B) before the clip is deployed and resection performed (C).
Page 6 of 9
F1000Research 2018, 7(F1000 Faculty Rev):304 Last updated: 12 MAR 2018
Figure 3. Current options for the resection of colonic neoplasia. EMR, endoscopic mucosal resection; ESD, endoscopic submucosal 
dissection; KAR, knife-assisted resection.
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